Updates on commercial insights and readiness plans for sozinibercept in wet AMD Opthea management to present in New York City on Tuesday, January 28 at 1:30 PM ET In-person events in Sydney on ...

To clarify the visual cues contributing to skin moisture and dryness, a research team conducted several psychophysical ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Citi has initiated coverage of EyePoint (EYPT) with a buy rating, stating it sees the company's drug Duravyu as well-positioned to compete in the wAMD market. Read more here.

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Want to improve your health and fitness in 2025? The good news is you don’t need a drastic lifestyle overhaul to make a difference. Small but impactful changes can significantly improve your wellbeing ...

Reducing the risk of eye diseases involves a combination of lifestyle changes, protective measures and regular eye care ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Social Security's "full retirement age" is set to increase next year, meaning that those nearing retirement will have to hold off a little longer before they can claim a larger benefit.

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Age-related macular degeneration (AMD ... approximately 30% progress to the severe vision loss associated with wet AMD within 10 years. The only FDA-approved treatments for dry AMD as of 2023 are two ...